{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:24:59Z","timestamp":1787599499983,"version":"build-2736575974"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"DOI":"10.1007\/s00380-026-02755-3","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T21:08:04Z","timestamp":1787173684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Letter to the editor: unaddressed research gaps in antithrombotic therapy following drug-coated balloon angioplasty for peripheral artery disease"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6425-8789","authenticated-orcid":false,"given":"Abdul Rehman","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2755_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-026-02730-y","author":"K Miki","year":"2026","unstructured":"Miki K, Hoshina R, Tanaka T, Tanaka H, Yanaka K, Yoshihara N, Saita T, Kimura T, Sumiyoshi A, Tamaru H, Imanaka T, Akahori H, Kawasaki D, Nishibori Y, Ishihara M (2026) Impact of 1-month dual antiplatelet therapy after treatment with drug-coated balloon for femoropopliteal artery disease. Heart Vessels. https:\/\/doi.org\/10.1007\/s00380-026-02730-y","journal-title":"Heart Vessels"},{"key":"2755_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.152.suppl_3.4358628","author":"V Le","year":"2025","unstructured":"Le V, Bair T, May H, Bride D, Anderson J, Muhlestein J, Knowlton K, Packer D, Knight S (2025) Abstract 4358628: prevalence of atrial fibrillation increases major adverse cardiovascular events, particularly heart failure hospitalization, in patients with peripheral arterial disease. Circulation. https:\/\/doi.org\/10.1161\/circ.152.suppl_3.4358628","journal-title":"Circulation"},{"issue":"1","key":"2755_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","volume":"67","author":"J Nordanstig","year":"2024","unstructured":"Nordanstig J, Behrendt CA, Baumgartner I, Belch J, B\u00e4ck M, Fitridge R, Hinchliffe R, Lejay A, Mills JL, Rother U, Sigvant B, Spanos K, Szeberin Z, van de Water W, ESVS Guidelines Committee, Antoniou GA, Bj\u00f6rck M, Gon\u00e7alves FB, Coscas R, Dias NV, Van Herzeele I, Lepidi S, Mees BME, Resch TA, Ricco JB, Trimarchi S, Twine CP, Tulamo R, Wanhainen A, Document Reviewers, Boyle JR, Brodmann M, Dardik A, Dick F, Go\u00ebffic Y, Holden A, Kakkos SK, Kolh P, McDermott MM (2024) Editor\u2019s choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication. Eur J Vasc Endovasc Surg 67(1):9\u201396. https:\/\/doi.org\/10.1016\/j.ejvs.2023.08.067","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"2755_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3400\/avd.oa.24-00056","volume":"17","author":"T Yamada","year":"2024","unstructured":"Yamada T, Tokuda T, Yoshioka N, Koyama A, Nishikawa R, Shimamura K, Aoyama T (2024) Comparison of single antiplatelet therapy and dual antiplatelet therapy after endovascular therapy in patients with lower extremity artery disease. Ann Vasc Dis 17(4):396\u2013404. https:\/\/doi.org\/10.3400\/avd.oa.24-00056","journal-title":"Ann Vasc Dis"},{"issue":"21","key":"2755_CR5","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","volume":"382","author":"MP Bonaca","year":"2020","unstructured":"Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, Fanelli F, Capell WH, Diao L, Jaeger N, Hess CN, Pap AF, Kittelson JM, Gudz I, M\u00e1ty\u00e1s L, Krievins DK, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR (2020) Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med 382(21):1994\u20132004. https:\/\/doi.org\/10.1056\/NEJMoa2000052","journal-title":"N Engl J Med"},{"issue":"7","key":"2755_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/ehjcvp\/pvae057","volume":"10","author":"M Galli","year":"2024","unstructured":"Galli M, Laudani C, Occhipinti G, Spagnolo M, Gragnano F, D\u2019Amario D, Navarese EP, Mehran R, Valgimigli M, Capodanno D, Angiolillo DJ (2024) P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother 10(7):588\u2013598. https:\/\/doi.org\/10.1093\/ehjcvp\/pvae057","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"15","key":"2755_CR7","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.jcin.2025.05.044","volume":"18","author":"C Laudani","year":"2025","unstructured":"Laudani C, Giacoppo D, Occhipinti G, Galli M, Greco A, Spagnolo M, Ortega-Paz L, Costa F, Angiolillo DJ, Capodanno D (2025) Aspirin or P2Y12 inhibitor monotherapy after percutaneous coronary intervention for acute coronary syndromes. JACC Cardiovasc Interv 18(15):1848\u20131859. https:\/\/doi.org\/10.1016\/j.jcin.2025.05.044","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-026-02755-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-026-02755-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-026-02755-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:02:37Z","timestamp":1787598157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-026-02755-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":7,"alternative-id":["2755"],"URL":"https:\/\/doi.org\/10.1007\/s00380-026-02755-3","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"15 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This Letter to the Editor is based on a discussion of existing literature and publicly available data. No new studies involving human or animal subjects were conducted by the authors. The authors affirm that all sources have been properly cited, and there are no conflicts of interest. The content adheres to ethical standards of academic integrity and responsible communication.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}